Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Sinopharm Group Co Ltd
SWB:X2S
Sinopharm Group Co Ltd
SWB:X2S
Price:
1.9565
EUR
5.39%
Market Closed
Market Cap:
€6.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
X2S Price Forecast
Based on 16 analysts
Based on 16 analysts
+24% Upside
from
€1.9565
today
Sinopharm Group Co Ltd (X2S)’s 12-month stock price forecast through November 2027 has a consensus target of €2.4283, implying 24% upside. The forecast is based on price targets from 16 Wall Street analysts.
X2S Analyst Rating
No ratings yet
No ratings yet
Sinopharm Group Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is X2S's stock price target?
Price Target
2.4283
EUR
2.4283
EUR
According to Wall Street analysts, the average 1-year price target for X2S is 2.4283 EUR with a low forecast of 1.9653 EUR and a high forecast of 3.2412 EUR.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Sinopharm Group Co Ltd?
Projected CAGR
2%
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 7%.
What is the Pre-Tax Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 5%.
